Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Ovarian highlights from ESMO 2019
Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
VELIA/GOG-3005 trial: Veliparib for high-grade serous carcinoma of ovarian, fall...
Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
PARP inhibitor olaparib added to bevacizumab benefits women with ovarian cancer ...
Prof Isabelle Ray-Coquard - The Université Claude Bernard Lyon, Lyon, France
Comment: PARP inhibitor olaparib plus bevacizumab in women with ovarian cancer
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
More ovarian cancer patients benefit from maintenance combined targeted therapy
Prof Isabelle Ray-Coquard - The Université Claude Bernard Lyon, Lyon, France
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
The potential of PARP inhibitors in new cancer groups and in combination with ot...
Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston,...
Cervical cancer screening in North Macedonia
Prof Shaban Memeti - Institute of Public Health, Skopje, North Macedonia
Exercise: How it can help both during and after cancer treatment
Liz Davis - Cancer Exercise Specialist, London, UK
Ovarian cancer: a current update
Prof Christina Fotopoulou - Queen Charlotte's and Chelsea Hospital, London, UK
Ovarian cancer: Current treatments and latest advances
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
The value of surgery in ovarian cancer
Prof Christina Fotopoulou - Queen Charlotte's and Chelsea Hospital, London, UK